LataMed AI reported cash from operations of -$0.03M and free cash flow of -$0.03M for the quarter ended Mar 2026, down 49.3% year over year. This cash flow statement covers 12 quarters of results from Jun 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | -0.02M | -2.94M | 1.24M | -0.04M | -1.53M | -0.04M | -0.92M | -0.02M | -0.03M | -0.04M | -0.12M | -0.05M |
| Cash from OperationsCash from Ops. | -0.01M | -0.04M | -0.03M | -0.01M | -0.01M | -0.01M | -0.02M | -0.01M | -0.01M | -0.16M | -0.03M | |
| Change in Working Capital | ||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.00M | 0.04M | 0.01M | 0.05M | 0.03M | 0.01M | 0.01M | 0.01M | 0.02M | -0.04M | 0.02M | |
| Financing Activities | ||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.01M | 0.04M | 0.03M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M | 0.16M | 0.03M | |
| Additional items | ||||||||||||
| Free Cash FlowFCF | -0.01M | -0.04M | -0.03M | -0.01M | -0.01M | -0.01M | -0.02M | -0.01M | -0.01M | -0.16M | -0.03M |